Revenue
2018
2019
2020
2021
2022
2023
2024
2025
DNA X, Inc. (SONM)
Price$3.99Cached quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $50.9M | $93.6M | $69.8M | $54.6M | $64.0M | $116.3M | $135.7M |
| Gross profit | $0 | $9.9M | $19.3M | $11.6M | $6.4M | $15.2M | $34.5M | $48.1M |
| Gross margin | — | 19.48% | 20.64% | 16.65% | 11.75% | 23.77% | 29.68% | 35.45% |
| Research & development | — | $14.2M | $1.8M | $8.0M | $17.7M | $16.2M | $26.1M | $23.2M |
| Operating expenses | $5.4M | $3.1M | $18.8M | $25.9M | $44.4M | $44.5M | $56.9M | $42.7M |
| Operating income | −$5.4M | −$3.1M | $513,000 | −$14.3M | −$38.0M | −$29.3M | −$22.4M | $5.4M |
| Operating margin | — | −6.09% | 0.55% | −20.46% | −69.64% | −45.72% | −19.25% | 3.98% |
| EBITDA | −$1.1M | $457,000 | $2.7M | −$11.9M | −$35.9M | −$26.5M | −$18.9M | $7.2M |
| EBITDA margin | — | 0.90% | 2.90% | −17.06% | −65.74% | −41.46% | −16.22% | 5.34% |
| Net income | −$20.7M | −$33.6M | −$90,000 | −$14.1M | −$38.6M | −$29.9M | −$25.8M | $1.3M |
| Net profit margin | — | −66.08% | −0.10% | −20.17% | −70.78% | −46.77% | −22.22% | 0.94% |
| Basic EPSper basic share | -$28.58 | -$128.37 | -$0.36 | -$8.82 | -$73.44 | -$116.64 | -$25.02 | -$46.26 |
| Diluted EPSper diluted share | -$28.58 | -$128.37 | -$0.36 | -$8.82 | -$73.44 | -$116.64 | -$25.02 | -$46.26 |
Owners
Reported shareholders
≈53.75%of listed shares
LYTTON LAURENCE W800K shares · Jun 30, 2025
View holders
| Holder | % owned |
|---|---|
Wang Jeffrey | —1.97M shares |
Narula Ashima / Orbic North America LLC / Narula Parveen | —1.95M shares |
LYTTON LAURENCE W | ≈53.75%800K shares |
Liu Hao Peter | —269.39K shares |
DNA Holdings Venture Inc. | ≈15.00%223.2K shares |
Becher Charles | ≈4.21%62.67K shares |
MULICA MICHAEL C | —54.07K shares |
Steenstra Jack | ≈3.30%49.14K shares |
Cassano James S | ≈3.30%49.13K shares |
Crolius Clayton | —36.72K shares |
C2C Wealth Management, LLC | 2.39%35.5K shares |
BlackRock, Inc. | 0.94%14.01K shares |
CITADEL ADVISORS LLC | 0.86%12.74K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.85%12.58K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.40%5.9K shares |
VANGUARD FIDUCIARY TRUST CO | 0.30%4.5K shares |
UBS Group AG | 0.15%2.3K shares |
Thangadurai George | ≈0.05%723 shares |
Tower Research Capital LLC (TRC) | 0.04%642 shares |
SBI Securities Co., Ltd. | 0.01%214 shares |
Percentages use 1.49M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 30, 2025Form 4 | LYTTON LAURENCE WTenPercentOwner | SellCommon Stock | 400.5K | $1.39 | $556.7K | 0 |
| Jun 26, 2025Form 4 | LYTTON LAURENCE WTenPercentOwner | SellCommon Stock | 466.4K | $1.50 | $699.6K | 400.5K |
| Apr 23, 2025Form 4 | Wang JeffreyDirector | SellCommon Stock | 4.5K | $1.45 | $6.5K | 21.3K |
| Apr 23, 2025Form 4 | Steenstra JackDirector | SellCommon Stock | 23.4K | $1.45 | $33.9K | 49.1K |
| Apr 23, 2025Form 4 | MULICA MICHAEL CDirector | SellCommon Stock | 27.8K | $1.45 | $40.3K | 73.3K |